Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team

Research

Independent equity research and analysis from our analyst team

Verve Q4'25: Burden of proof remains on cash flows
Research2/20/2026, 7:02 AM by
Christoffer Jennel

Verve Q4'25: Burden of proof remains on cash flows

The detailed cash flow statement reinforced our concern about weak cash flows, which continue to challenge our investment thesis.

Verve Group
Norrhydro Q4'25: Further evidence of earnings turnaround
Research2/20/2026, 9:00 AM by
Pauli Lohi

Norrhydro Q4'25: Further evidence of earnings turnaround

Earnings turnaround facilitates balance sheet strengthening and lowers the earnings-based valuation.

Norrhydro Group
Starbreeze Q4'25: The path forward has narrowed
Research2/20/2026, 6:07 AM by
Christoffer Jennel

Starbreeze Q4'25: The path forward has narrowed

Starbreeze delivered Q4 revenue clearly below our expectations, with the shortfall primarily driven by a particularly weak PAYDAY 3 (“PD3”) contribution.

Starbreeze

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Lemonsoft Q4'25: AI fears seem overblown
Research2/20/2026, 8:28 AM by
Atte Riikola

Lemonsoft Q4'25: AI fears seem overblown

The company's Q4 earnings met our expectations, and the outlook for this year anticipates continued earnings growth in line with our forecasts.

Lemonsoft
Rovsing (One-pager): Near-term headwinds, growing tender activity, and a new ESA cycle ahead
Research2/19/2026, 2:45 PM by
Michael Friis, Victor Skriver

Rovsing (One-pager): Near-term headwinds, growing tender activity, and a new ESA cycle ahead

In connection with the interim report for H1 2025/26, we have updated our one-pager analysis. Read more about valuation perspectives and the key investment reasons and risks.

Rovsing
Digital Workforce Q4'25: Time to deliver this year
Research2/19/2026, 11:25 AM by
Joni Grönqvist

Digital Workforce Q4'25: Time to deliver this year

The strategy is resonating, and important strategic victories have been achieved early in the year. Now, we are still awaiting clearer confirmation of growth and its scaling into profitability.

Digital Workforce
Initiation of coverage: Inderes — From Finnish roots to scalable platforms
Extensive research2/18/2026, 6:00 AM by
Matias Sainio, Joonas Sjöblom, Tino Korjala

Initiation of coverage: Inderes — From Finnish roots to scalable platforms

Inderes Oyj is a Finnish investor communications company specializing in equity research, IR software, event production, and a digital investor community. The company serves over 400 corporate clients across the Nordics and operates an asset-light business model supported by recurring contracts and long-standing customer relationships. This foundation enhances revenue visibility and supports stable cash generation.

Inderes
Apetit Q4'25: Strategy period begins with weaker performance
Research2/16/2026, 11:07 AM by
Pauli Lohi

Apetit Q4'25: Strategy period begins with weaker performance

The profitability of the Finnish businesses has been a slight disappointment, and in addition, the acquired Foodhills would need an earnings turnaround.

Apetit
HKFoods Q4'25: Value boosted by earnings growth and leverage
Research2/16/2026, 11:39 AM by
Pauli Lohi

HKFoods Q4'25: Value boosted by earnings growth and leverage

The operating environment and the company's own actions support earnings growth in 2026.

HKFoods
Kalmar Q4'25: Boost from record orders
Research2/16/2026, 9:25 AM by
Aapeli Pursimo

Kalmar Q4'25: Boost from record orders

Kalmar's Q4 result fell slightly short of our expectations due to margin development. Meanwhile, orders soared to record levels, blowing both our forecasts and the consensus out of the water.

Kalmar
Exel Composites Q4'25: Growth to accelerate, rate remains a question mark
Research2/16/2026, 8:40 AM by
Aapeli Pursimo

Exel Composites Q4'25: Growth to accelerate, rate remains a question mark

Exel's operational development in Q4 fell short of our expectations, while its order intake was at a record high.

Exel Composites
Enento Q4'25: Earnings growth outlook gained further clarity
Research2/16/2026, 7:55 AM by
Roni Peuranheimo

Enento Q4'25: Earnings growth outlook gained further clarity

Enento's Q4 result exceeded our estimates due to strong profitability development.

Enento Group
Eltel Q4'25: Margin streak hits double digits
Research2/16/2026, 5:45 AM by
Christoffer Jennel

Eltel Q4'25: Margin streak hits double digits

Eltel's finished 2025 on a high note, with Q4 revenue coming in 4% above our estimates and margins continuing their year-on-year improvement for the tenth consecutive quarter.

Eltel
Koskisen Q4'25: We see no conflict between price and value
Research2/16/2026, 11:39 AM by
Antti Viljakainen

Koskisen Q4'25: We see no conflict between price and value

We reiterate our EUR 9.00 target price and Reduce recommendation for Koskisen. We lowered our near-term estimates for Koskisen slightly, as the guidance for the current year was a bit more cautious than we expected. We see clear earnings growth potential for Koskisen in the coming years, as the construction cycle gradually recovers and the company's substantial investments over the past years reach fruition. However, we believe this has already been adequately priced into the share (2026e: P/E 12x), which is why the expected return on the share will not exceed the required return for the time being.

Koskisen
Teleste Q4'25: Well-progressing North America conquest supports valuation
Research2/16/2026, 6:42 AM by
Atte Riikola, Roni Peuranheimo

Teleste Q4'25: Well-progressing North America conquest supports valuation

Teleste's Q4 result was in line with our expectations, and the outlook for the current year anticipates continued earnings growth as expected.

Teleste
Björn Borg Q4'25: Margin strength drive an upgrade
Research2/16/2026, 5:30 AM by
Lucas Mattsson

Björn Borg Q4'25: Margin strength drive an upgrade

Björn Borg delivered strong Q4 earnings, due to solid sales volumes and good cost control. In our view, the outlook for next year is positive, and combined with a strong finish to last year, this has led us to raise our earnings estimates for the coming years. With our updated estimates, the company’s earnings multiples for this year are at the lower end of our acceptable valuation range, with a P/E ratio of around 15x and EV/EBIT of 12x. As a result, we raise our recommendation to Accumulate (prev. Reduce) and increase our target price to SEK 67 per share (prev. SEK 57 per share), mainly due to increased estimates.

Björn Borg
Relais Q4'25: New period will focus on efficiency
Research2/16/2026, 10:25 AM by
Petri Gostowski

Relais Q4'25: New period will focus on efficiency

Relais' Q4 figures were clearly below our estimates, as organic revenue development in particular was sluggish in both businesses.

Relais Group
Bioretec Q4'25: Groundwork for improved commercial execution
Research2/16/2026, 8:35 AM by
Antti Siltanen

Bioretec Q4'25: Groundwork for improved commercial execution

Bioretec is rebuilding commercial and investor confidence.

Bioretec
Tieto's company coverage ends
Research2/13/2026, 1:03 PM by
Joni Grönqvist

Tieto's company coverage ends

We are discontinuing our research coverage of Tietoevry, and therefore we no longer issue a target price (was EUR 18.0) or recommendation (was Reduce) for the share. We recommend that investors continue to follow the company's own stock exchange and investor communications. In addition, the company's announcements and related discussions can be found on the Inderes website.

Tietoevry
NYAB Q4'25: Quality at a deep discount
Research2/13/2026, 6:18 AM by
Christoffer Jennel

NYAB Q4'25: Quality at a deep discount

NYAB delivered Q4 revenues in line with our estimate, while EBIT surpassed our estimates, with management commentary indicating that utilization of the expanded workforce has normalized sooner than we anticipated.

NYAB
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.